The committee reviewed existing and in-progress clinical research before proceeding to discussion. In discussing the literature, the Committee emphasized there is a large imbalance between studies performed on animals (90 percent) and studies performed on humans (10 percent). The discrepancy makes it difficult to draw conclusions about risk levels for anesthesia in children.
Read the ASA release on the FDA meeting on pediatric anesthesia.
Read more on anesthesia:
–Changes to Epidural Doses Allow Movement Without Pain
–Anesthesiologist on the Move: Dr. Suwarna Bhide Deoskar Joins Essentia Health
–Drug Shortages Force California Facilities to Look for Alternatives
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
